Usage of this synthetic global page : surf the table, re-organise
the table (sort it with one click or two clicks on a column title),
direct access to a given company by pointing the name in the list
below (all explanations in 'Legends', full details of a given company
in 'Companies', in the above toolbar)

Contract, Services(also, Discovery, Targets)Key words: Gene expression, Protein production, Gene delivery, Insect cells expression, Baculovirus, BacTenMission: to provide third parties with services ranging from gene cloning to protein (or virus) production (resp. purification), acting as a vector developer, either for protein production or for gene transfer, as well as a manufacturing partner, to to develop new systems and technologies in the gene expression, gene transfer and delivery areasClients: Pharmaceutical industry, Biotech, Research labs Age: 12 year(s)

Discovery, DrugsKey words: Protein interactions, Condyloma, Anti-viralMission: to develop a proprietary platform for the discovery of small molecules that disrupt protein:protein interactions, as a distinct unexploited class of pharmaceutical targets, due to the difficulty of recognizing drugable hot-spots on the surface of interacting proteinsClients: Prescribers Age: 14 year(s)

Contract, ManufacturingKey words: Therapeutic proteins, Gene expression, Transgenic rabbitsMission: to provide third parties with production of recombinant therapeutic proteins and vaccines in the milk of transgenic rabbits, as a fully integrated service from gene expression to industrial production of purified proteins and vaccinesClients: Pharma industry, Research labs, Biotechs Age: 19 year(s)

Notes (February 2012) : the company website is unavailable and the URL does not exist any more since 2010, but a legal process with board meeting occurred in August 2010 (still the same, in September 2011) and a board meeting occured in December 2011 and an AGM in August 2012

Design, Drugs(also Design, Diagnostics)Key words: Immunochemistry, MABs, Polyclonal antibodiesMission: to supply innovative and unique polyclonal and monoclonal antibodies to third parties, such as universities, research institutes and commercial organisations around the worldClients: Research labs Age: 22 year(s)

Discovery, Diagnostics(also, Discovery, Drugs)Key words: RNA splicing, Gene profiling technology, Cancer, AlzheimerMission: to leverage on alternative RNA splicing, the process by which a single gene can lead to several proteins in the fields of drug discovery, diagnostics and biochips and to sell proprietary gene profiling technology named Datas in order to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of diseaseClients: Pharmaceutical industry (own development up to phase II) Age: 20 year(s)

Discovery, ImmunologyKey words: Flu, C-Hepatitis, Mimetic particles, Virus-like particle vaccinesMission: to develop a platform technology for a new generation of Virus-Like Particle vaccines (eVLP) that may allow to quickly manufacture seasonal or pandemic flu vaccines, to treat Hepatitis C, and to be applied to other infectious diseases, such as HPV or HIVClients: Pharmaceutical industry Age: 14 year(s)

Contract, ResearchKey words: DNA, Genome, Sequencing, Genotyping, Mutation detection, Gene expression, Microbial identification, Microbial typingMission: to develop and to realize innovative services on all kind of genomes to provide answers that best suit the needs of research laboratories, by using own high throughput equipmentsClients: Pharmaceutical industry, Research labs, Life science industries, Academic research institutions Age: 17 year(s)

Discovery, DrugsKey words: Hemoglobin, Blood-transfers, Transfusion, Sea-Invertebrate, ArenicoleMission: to develop a new generation of oxygen-carrier for therapeutical and industrial applications (to help cope with the huge deficit of blood worldwide), based on extraction and purification from a marine organismClients: Pharmaceutical industry (developement limited to early stage), Biotechs Age: 10 year(s)

Design, Diagnostics(also, Discovery, Diagnostics)Key words: Research reagents, Thrombosis, Haemostasis, Auto-Immunity, ZymutestMission: to develop a full line of innovative kits in diagnostic and research reagents and biochemicals, manual or automated, designed with clotting, chromogenic or immunological methods, for the exploration of Thrombosis, Haemostasis, Fibrinolysis and Auto-ImmunityClients: Research labs, Pharmaceutical industry Age: 19 year(s)

Contract, ManufacturingKey words: DNA-conservation, Encapsulation, ExtractionMission: to provide third parties with high quality, long term preservation of DNA at room temperature for large scale genomic resources banksClients: Research labs Age: 19 year(s)

Discovery, Immunology(also, Discovery, Diagnostics)Key words: HIV, CD4 restoration, Predictive testMission: to develop a new HIV therapeutic vaccine aiming to restore CD4 to normal levels (without immunodeficiency) and to design a diagnostics test able to predict the evolution of the AIDS pathology of a given patientClients: Pharmaceutical industry Age: 9 year(s)

Design, DrugsKey words: Cell therapy project, Transplantation, CardiovascularMission: to carry out an autologous gingival fibroblasts transplantation in order to repair injured tissues, in particular in the field of cardiovascular pathology (vascular prosthesis for abdominal aortic aneurysm, atherosclerosis,…) and othersClients: undisclosed Age: 10 year(s)

Spin-off | Managing Dir.-CEO: Augier (Jean-Jacques) [legally as President, born 1953]Sc.Dir.-CSO: Fin.Dir.-CFO: BusDev: Financers (Hist.): Note : URL not renewed in time (October 2009), still unavailable (February, May, October 2010, April 2011, December 2012), but legally company still active (with a new President since July 2012, Laurent Cezard, born March 1969

Contract, ResearchKey words: Preclinical development, CNS, Epilepsy, Neuronal networksMission: to provide third parties with customized solutions for preclinical evaluation of CNS therapeutics and with consulting, pre-designed and customized programs to expertise drug candidates of the biopharmaceutical industry, and also to develop own research innovative toolsClients: Research labs Age: 12 year(s)